Exploring the acceptability, appropriateness, feasibility and satisfaction of an implementation strategy for out-of-HOspital administration of the Long-Acting combination of cabotegravir and rilpivirine as an optional therapy for HIV in Spain (the HOLA study)-a hybrid implementation-effectiveness, phase IV, double-arm, open-label, multicentric study: study protocol
on 30 de juny de 2025
with No hi ha comentaris
Negredo, E., Hernández-Sánchez, D., Álvarez-López, P., Falcó, V., Rivero, A., Jusmet, J., …Olalla, J. (2025). Exploring the acceptability, appropriateness, feasibility … Read More